What Is Pathways To Trust All About?
At Pathways To Trust, our mission is to bring stakeholders together to restore trust in healthcare with a focus on rare disease patients. We believe the best way to do this is by helping healthcare providers communicate with patients and caregivers better by offering disease-specific, customized training that addresses real-world encounters with rare disease patients. By participating in our innovative programs -- which could be a game changer for the healthcare industry -- HCPs of all experience levels markedly improve their listening skills, empathize with the patient and caregiver experience, and communicate with them effectively and compassionately, leading to improved health and emotional outcomes. These outcomes, in turn, lead to benefits for other stakeholders including treatment adherence, fewer hospitalizations and more controlled costs.
Cheryl Lloyd
Executive Director
Cheryl brings 30 years of experience as a producer and trainer for Fortune 500 companies to the healthcare industry. For the past ten years, as a principal of a video production company that facilitates compassionate communication trainings for HCPs, she has produced successful experiential learning for medical professionals, Cheryl co-founded Pathways To Trust to improve health outcomes by increasing respect for the patient’s point of view and involving all stakeholders in the conversation.
Maybelle Lincoln
Communications Director
Maybelle brings 25 years of experience in the healthcare industry and a lifetime of knowledge about life as a rare disease patient. As a co-founder of Pathways To Trust, Maybelle leverages her expertise as a pharmaceutical/managed care copywriter and freelance medical copywriter to facilitate communication among healthcare stakeholders. For the past 10 years, Maybelle has executed successful HCP communication training events throughout New Jersey as well as in North Carolina and Texas.
Kay-Diene Robinson
Director of Patient Advocacy
Kay-Diene Robinson, MPH, CHW is a former sickle cell Hemoglobin-SS patient, cured by a bone marrow transplant, who now devotes her energy and time to advocating on behalf of all sickle cell patients, particularly in New Jersey. Since 2013 she has been a volunteer Peer Leader with the Sickle Cell Association of New Jersey, and in April 2018 she completed the Community Health Worker training with the SCDAA. She has also participated in webinars and educational symposiums with the SCDAA and hospital systems.
